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Introduction
Hepatic encephalopathy (HE) is a neurological complica-
tion of cirrhosis, impairing survival and quality of life. Its
incidence is growing because of the improved prognosis of
other complications of cirrhosis, and of the widespread
use of TIPS. However, besides hyperammonemia which is
often pointed out as a cause of HE, the pathophysiological
mechanisms of HE remains poorly understood, which pre-
vents the development of therapeutic strategies. To
address this issue, metabolomics was used to identify dys-
function of metabolic pathways in cerebrospinal fluid
(CSF) samples of cirrhotic patients suffering from HE.
Objectives
The aim of this study was to detect new therapeutic tar-
gets for HE associated with cirrhosis.
Methods
Cerebrospinal Fluid (CSF) samples were collected on
14 cirrhotic patients admitted in ICU for HE, in whom
infection of central nervous system has to be ruled out,
and were compared to CSF of 27 control patients with-
out any proven neurological disease. Metabolomic analy-
sis was performed using 3 liquid chromatographies
coupled to high resolution mass spectrometry methods
(LC-HRMS). Informatic data processing tools were used.
Results
LC-HRMS methods led to the characterization of
150 metabolites in CSF samples of HE patients, which
were mainly amino acids and organic acids. Interestingly,
according to human metabolome database, 40% of those
metabolites had never been retrieved were not reported as
present in CSF before. HE patients could be easily discri-
minated from controls on the basis of metabolomicic
information. Concentrations of 102 metabolites were
found to be significantly altered in HE patients: metabolo-
types displayed alterations in several major metabolite
classes such as ammoniac, bile acids, but also amino-acids,
acylcarnitines, and nucleosides. Accumulations of acety-
lated compounds, which could be due to a defect of the
Krebs cycle, were reported for the first time in HE
patients, and could constitute interesting therapeutic
targets.
Conclusions
By enabling the simultaneous monitoring of a large set of
metabolites in cirrhotic patients with HE, CSF metabolo-
mics highlighted several altered metabolite pathways
linked to ammonia metabolism, neurotransmission and
energy metabolism. The pharmacological relevance of our
findings has to be explored on animal models, as they
could constitute interesting new therapeutic targets.
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